Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications.

Mishra S, Van Rechem C, Pal S, Clarke TL, Chakraborty D, Mahan SD, Black JC, Murphy SE, Lawrence MS, Daniels DL, Whetstine JR.

Cell. 2018 Nov 29;175(6):1716. doi: 10.1016/j.cell.2018.11.018. No abstract available.

PMID:
30500540
2.

Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications.

Mishra S, Van Rechem C, Pal S, Clarke TL, Chakraborty D, Mahan SD, Black JC, Murphy SE, Lawrence MS, Daniels DL, Whetstine JR.

Cell. 2018 Aug 9;174(4):803-817.e16. doi: 10.1016/j.cell.2018.06.018. Epub 2018 Jul 26. Erratum in: Cell. 2018 Nov 29;175(6):1716.

PMID:
30057114
3.

E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression.

Guarner A, Morris R, Korenjak M, Boukhali M, Zappia MP, Van Rechem C, Whetstine JR, Ramaswamy S, Zou L, Frolov MV, Haas W, Dyson NJ.

Dev Cell. 2017 Dec 18;43(6):689-703.e5. doi: 10.1016/j.devcel.2017.11.008. Epub 2017 Dec 7.

PMID:
29233476
4.

Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.

Wang M, Han J, Marcar L, Black J, Liu Q, Li X, Nagulapalli K, Sequist LV, Mak RH, Benes CH, Hong TS, Gurtner K, Krause M, Baumann M, Kang JX, Whetstine JR, Willers H.

Cancer Res. 2017 Apr 15;77(8):2018-2028. doi: 10.1158/0008-5472.CAN-16-0808. Epub 2017 Feb 15.

5.

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference.

Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, Kelley RK, Kwong LN, Lowery M, Merrell A, Miyabe K, Rhim A, Saha S, Sia D, Tanasanvimon S, Venook A, Valle JW, Walesky C, Whetstine J, Willenbring H, Zhu AX, Mayer D, Stanger BZ.

J Gastrointest Oncol. 2016 Dec;7(6):819-827. doi: 10.21037/jgo.2016.11.11. No abstract available.

6.

Regulation of Transient Site-specific Copy Gain by MicroRNA.

Black JC, Zhang H, Kim J, Getz G, Whetstine JR.

J Biol Chem. 2016 Mar 4;291(10):4862-71. doi: 10.1074/jbc.M115.711648. Epub 2016 Jan 11.

7.

Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive.

Mishra S, Whetstine JR.

Mol Cell Biol. 2016 Jan 11;36(7):1050-63. doi: 10.1128/MCB.00652-15. Review.

8.

RNF2 E3 or Not to E3: Dual Roles of RNF2 Overexpression in Melanoma.

Black JC, Whetstine JR.

Cancer Discov. 2015 Dec;5(12):1241-3. doi: 10.1158/2159-8290.CD-15-1285.

9.

Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.

Wagschal A, Najafi-Shoushtari SH, Wang L, Goedeke L, Sinha S, deLemos AS, Black JC, Ramírez CM, Li Y, Tewhey R, Hatoum I, Shah N, Lu Y, Kristo F, Psychogios N, Vrbanac V, Lu YC, Hla T, de Cabo R, Tsang JS, Schadt E, Sabeti PC, Kathiresan S, Cohen DE, Whetstine J, Chung RT, Fernández-Hernando C, Kaplan LM, Bernards A, Gerszten RE, Näär AM.

Nat Med. 2015 Nov;21(11):1290-7. doi: 10.1038/nm.3980. Epub 2015 Oct 26.

10.

SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes.

Tajima K, Yae T, Javaid S, Tam O, Comaills V, Morris R, Wittner BS, Liu M, Engstrom A, Takahashi F, Black JC, Ramaswamy S, Shioda T, Hammell M, Haber DA, Whetstine JR, Maheswaran S.

Nat Commun. 2015 Sep 23;6:8257. doi: 10.1038/ncomms9257.

11.

Too little O2 Too much gain.

Black JC, Whetstine JR.

Cell Cycle. 2015;14(18):2869-70. doi: 10.1080/15384101.2015.1076659. Epub 2015 Jul 29. No abstract available.

12.

Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.

Black JC, Atabakhsh E, Kim J, Biette KM, Van Rechem C, Ladd B, Burrowes PD, Donado C, Mattoo H, Kleinstiver BP, Song B, Andriani G, Joung JK, Iliopoulos O, Montagna C, Pillai S, Getz G, Whetstine JR.

Genes Dev. 2015 May 15;29(10):1018-31. doi: 10.1101/gad.259796.115.

13.

A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.

Van Rechem C, Black JC, Greninger P, Zhao Y, Donado C, Burrowes PD, Ladd B, Christiani DC, Benes CH, Whetstine JR.

Cancer Discov. 2015 Mar;5(3):245-54. doi: 10.1158/2159-8290.CD-14-1159. Epub 2015 Jan 6.

14.

Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.

Van Rechem C, Black JC, Boukhali M, Aryee MJ, Gräslund S, Haas W, Benes CH, Whetstine JR.

Cancer Discov. 2015 Mar;5(3):255-63. doi: 10.1158/2159-8290.CD-14-1326. Epub 2015 Jan 6.

15.

Methylation: a multifaceted modification - looking at transcription and beyond.

Whetstine JR.

Biochim Biophys Acta. 2014 Dec;1839(12):1351-2. doi: 10.1016/j.bbagrm.2014.09.005. Epub 2014 Sep 16. No abstract available.

PMID:
25225044
16.

Examining the impact of gene variants on histone lysine methylation.

Van Rechem C, Whetstine JR.

Biochim Biophys Acta. 2014 Dec;1839(12):1463-76. doi: 10.1016/j.bbagrm.2014.05.014. Epub 2014 May 23. Review.

17.

Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1.

Javaid S, Zhang J, Anderssen E, Black JC, Wittner BS, Tajima K, Ting DT, Smolen GA, Zubrowski M, Desai R, Maheswaran S, Ramaswamy S, Whetstine JR, Haber DA.

Cell Rep. 2013 Dec 26;5(6):1679-89. doi: 10.1016/j.celrep.2013.11.034. Epub 2013 Dec 19.

18.

Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.

Rottiers V, Obad S, Petri A, McGarrah R, Lindholm MW, Black JC, Sinha S, Goody RJ, Lawrence MS, deLemos AS, Hansen HF, Whittaker S, Henry S, Brookes R, Najafi-Shoushtari SH, Chung RT, Whetstine JR, Gerszten RE, Kauppinen S, Näär AM.

Sci Transl Med. 2013 Nov 20;5(212):212ra162. doi: 10.1126/scitranslmed.3006840.

19.

KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.

Black JC, Manning AL, Van Rechem C, Kim J, Ladd B, Cho J, Pineda CM, Murphy N, Daniels DL, Montagna C, Lewis PW, Glass K, Allis CD, Dyson NJ, Getz G, Whetstine JR.

Cell. 2013 Aug 1;154(3):541-55. doi: 10.1016/j.cell.2013.06.051. Epub 2013 Jul 18.

20.

Detection of impaired homologous recombination repair in NSCLC cells and tissues.

Birkelbach M, Ferraiolo N, Gheorghiu L, Pfäffle HN, Daly B, Ebright MI, Spencer C, O'Hara C, Whetstine JR, Benes CH, Sequist LV, Zou L, Dahm-Daphi J, Kachnic LA, Willers H.

J Thorac Oncol. 2013 Mar;8(3):279-86. doi: 10.1097/JTO.0b013e31827ecf83.

Supplemental Content

Loading ...
Support Center